Bassam Janji

20PUBLICATIONS
48CO-AUTHORS
Cancer cell biologySpeciation and extinctionInnate immunityMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 13, 2026
Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy.

|Apr 13, 2026
VPS34 in Autophagy, Cancer, and Cancer Therapy.

Elisabetta Bartolini, Bassam Janji, Ruize Gao

|May 21, 2025
Unleashing anti-tumor immunity: Targeting the autophagy-related protein VPS34 to enhance STING agonist-based therapy.

Elisabetta Bartolini, Kris Van Moer, Bassam Janji

|Apr 18, 2025
Targeting the atypical chemokine receptor 2 (Ackr2) improves the benefit of anti-PD-1 immunotherapy in melanoma mouse model.

Muhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao

|Jun 14, 2024
Improving STING agonist-based cancer therapy by inhibiting the autophagy-related protein VPS34.

Elisabetta Bartolini, Kris Van Moer, Bassam Janji

|Mar 20, 2024
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.

Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman

Pageof 4

Frequent Collaborators

8 joint publications

Guy Berchem

4 joint publications

Malina Xiao

2 joint publications

Muhammad Zaeem Noman

2 joint publications

Santiago Parpal